Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Panomics Relationships in the Epidemiology of Cancer Through In Silico Expression (PRECISE)
Withdrawn
- Conditions
- Patients With a Suspected or Confirmed Diagnosis of CancerCancerPatients With Clinical and Environmental Risk Factors for Cancer
- First Posted Date
- 2017-10-09
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Greater Baltimore Medical Center
- Registration Number
- NCT03304990
- Locations
- 🇺🇸
Greater Baltimore Medical Center, Baltimore, Maryland, United States
Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
- First Posted Date
- 2017-09-18
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Greater Baltimore Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT03285802
- Locations
- 🇺🇸
Greater Baltimore Medical Center, Baltimore, Maryland, United States
News
No news found